CliffBio
small molecule

GEMCITABINE HYDROCHLORIDE

GEMCITABINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameGEMCITABINE HYDROCHLORIDE
Active ingredientGEMCITABINE HYDROCHLORIDE
Strength200MG/5.26ML (38MG/ML)
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMay 2017
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.